Sinofn Health
Sinofn Health
Innovative medical foods, specialized dietary supplements, and clinical nutrition tailored for distributors and pharmacies across Windhoek, Swakopmund, and the wider SADC territory.
Namibia is witnessing a significant transformation in its public health and preventive medicine landscape. Due to a combination of rising disposable incomes, expanding urban populations in regional hubs like Windhoek, Walvis Bay, and Swakopmund, and a greater awareness of nutritional deficiencies, the demand for high-quality clinical nutrition and dietary supplements is at an all-time high.
Historically, the Namibian pharmaceutical sector has relied heavily on imported finished products from South Africa and Europe. However, global supply chain disruptions have underscored the need for local brands to establish secure, agile manufacturing partnerships. By leveraging the expertise of an established global OEM/ODM manufacturer like SINOFN, Namibian brands can rapidly commercialize international-standard products optimized for local demographics without the capital-intensive requirement of building local production facilities.
Through bilateral trading arrangements and regional treaties like the Southern African Customs Union (SACU) and SADC, products imported through streamlined ports like the Port of Walvis Bay can quickly access a regional market of over 380 million consumers. SINOFN provides a direct bridge to this opportunity, delivering advanced formulation science, clinical validation, and massive production capacities.
Our OEM/ODM services cater to the specific regulatory and logistical framework of Southern Africa, ensuring that formulations comply with the Namibia Medicines Regulatory Council (NMRC) guidelines.
With our bulk production capabilities and optimized packaging options, Namibian distributors can manage lead times effectively, maintaining consistent stock levels across hospital and retail pharmacy chains.
SINOFN Health Co., Ltd. is the dedicated contract manufacturing division of the SINOFN Group—a national high-tech enterprise founded in 2012 in partnership with the prestigious Chinese Academy of Sciences (CAS). Established in 2025 as the global outbound arm based in Shanghai, we serve as the premier trading and support hub for international distributors seeking clinically backed supplement manufacturing.
Our foundational vision was born out of a commitment to accessibility and clinical utility. We bridge the gap between high-end scientific research and practical, everyday health solutions. We specialize in contract manufacturing across a variety of delivery formats, including softgels, custom gummies, functional liquids, and therapeutic powders. From clinical foods for inherited metabolic disorders (such as Phenylketonuria) to advanced sports performance nutrition, our operations are optimized to handle both large-scale commercial runs and pilot-phase prototyping.
"During her clinical work, our founder Mrs. GuoHong Liu witnessed the lifelong struggles of families dealing with Phenylketonuria (PKU), where specialized diets were financially out of reach. Driven to bridge this gap, she established SINOFN in 2012 to develop affordable, science-backed therapeutic foods."
- GuoHong Liu
Founder, SINOFN Group
A portion of all clinical nutrition revenues is systematically dedicated to PKU accessibility initiatives in developing healthcare markets.
We leverage top-tier global biotechnology talent to engineer high-biodiversity formulation systems, ensuring stability and clinical efficacy in every batch.
Ph.D. from Peking University Medical School. With over 15 years of experience in metabolic disorder formulations, he oversees clinical validation and product efficacy profiles.
Associate Researcher and Chinese Academy of Sciences (CAS) Postdoctoral Fellow. Specializes in advanced bioactive compound delivery systems and microencapsulation.
Senior Scientist hailing from the Netherlands. A specialist in EU regulatory affairs and clinical nutraceutical delivery systems, ensuring compliance across SADC and European markets.
Aligning global health innovations with the local application scenarios of Southern Africa.
Standard dietary supplements often suffer from poor gastrointestinal absorption. Our formulation lab focuses on advanced liposomal encapsulation and peptide conjugation. By binding active compounds to transport peptides, we bypass typical digestive degradation, ensuring that vitamins, minerals, and functional botanical extracts deliver therapeutic outcomes at lower, safer doses.
Namibia's arid, high-temperature climate poses challenges for product shelf-life and active ingredient stability. SINOFN utilizes advanced moisture-barrier coatings for tablets and nitrogen-flushed sachet packaging for solid drink mixes. This prevents degradation during transport through desert regions and storage in standard retail environments.
Globally, consumers are demanding transparency in ingredient sourcing. We provide comprehensive clean-label options, substituting synthetic binders and fillers with plant-based prebiotics, organic soluble fibers, and natural flavor systems. This trend is highly compatible with the expanding natural health retail segment in Windhoek.
Foods for Special Medical Purposes (FSMP) require strict separation of production lines to prevent cross-contamination. Our facility houses dedicated zones for allergen-free and metabolic-disorder formulations, including phenylalanine-free matrices for PKU management, supporting regional clinical nutrition programs.
A closer look at the infrastructure that powers our global supply chain.
Over 10 dedicated manufacturing lines for softgels, gummies, liquids, and powders. Annual capacity exceeds 500 million units.
Equipped with HPLC and GC-MS equipment for rigorous contaminant screening, purity evaluation, and raw material validation.
Pilot-scale prototyping chambers for solid drink and liquid systems, validating dissolution profiles and stability metrics.
End-to-end integration utilizing blockchain batch tracking from raw material acquisition to final export shipment.
SINOFN prioritizes intellectual property, holding 36 patents (including 11 invention patents) and 71 multi-category trademarks. Our production sites maintain full compliance with ISO 9001, ISO 22000, HACCP, and HALAL standards.
Explore our complete range of customizable products, optimized for regional distribution, pharmaceutical retail, and therapeutic applications.
Crucial information regarding compliance, formulation capabilities, and logistics for partners in Namibia and the wider Southern African region.
Importing nutritional supplements and special medical foods into Namibia requires compliance with the Namibia Medicines Regulatory Council (NMRC). SINOFN assists you by providing complete dossier support, including detailed Certificates of Analysis (COAs), stability data, allergen statements, and GMP certificates to facilitate a smooth registration process.
Yes. Our R&D team, led by Dr. Zhang Ying and Hans van Dijk, routinely collaborates with clients to develop formulations targeting regional health priorities in Southern Africa. This includes nutrient-dense powder supplements, high-bioavailability prenatal formulas, and specialized foods for metabolic disorders like Phenylketonuria (PKU).
MOQs vary depending on the dosage form. Generally, for specialized capsules and tablets, MOQs start at 100,000 units. For customized solid drinks, energy gels, and prebiotic liquid sachets, the standard MOQ is 20,000 to 50,000 sachets. We also offer smaller pilot runs for clinical validation and localized market testing.
We manage direct sea freight from the Port of Shanghai to the Port of Walvis Bay. From Walvis Bay, secure road freight networks handle transit to distribution hubs in Windhoek. All export packaging features high-grade moisture barriers and temperature monitoring to protect cargo throughout transit.
Yes. Our comprehensive ODM services include label and packaging design. We ensure all packaging conforms to Namibian regulations regarding language, ingredient labeling, and serving size disclosures, allowing your brand to enter the market with minimal regulatory friction.
